Roche To Acquire Carmot Therapeutics For $2.7 Bln Cash Plus Milestone Payments
4/12 07:39
(RTTNews) - Swiss drug major Roche Holding AG (RHHBY) announced Monday that it has signed a definitive merger agreement to acquire Carmot Therapeutics, Inc., a privately owned US clinical-stage biotechnology company, for $2.7 billion upfront in cash at the closing of the transact...